跳至主要内容
临床试验/CTRI/2026/01/100109
CTRI/2026/01/100109尚未招募2 期

A Randomized Comparative Clinical Trial to evaluate the efficacy of Shiroabhyanga, Padabhyanga and Pratimarsha Nasya compared with Ashwagandha Churna in Premenstrual Syndrome

National Institute of Ayurveda1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2026年3月3日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
80
试验地点
1

研究概览

简要总结

RESEARCH QUESTIONIs there any difference between the efficacy of Shiroabhyang, Padabhyanga, Pratimarsha Nasya        and Ashwagandha Churna in management of PMS (w.s.r. Rituvyatit Kalaja Pitta Vata Vriddhi)?

HYPOTHESIS

**Null Hypothesis [Ho] -**There is no difference in the efficacy of Shiroabhyanga, Padabhyanga and Pratimarsha Nasya as compared with Ashwagandha Churna in PMS (w.s.r. Rituvyatit Kalaja Pitta Vata Vriddhi).

 Alternative Hypothesis [HA]- There is difference in the efficacy of Shiroabhyanga, Padabhyangaand Pratimarsha Nasya as compared with Ashwagandha Churna in PMS (w.s.r. Rituvyatit Kalaja Pitta Vata Vriddhi).

    AIMTo evaluate the efficacy of selected Dinacharya procedures (Shiroabhyanga, Padabhyanga, and Pratimarsha Nasya) in comparison with Ashwagandha Churna in PMS (w.s.r. to Rituvyatit Kalaja Pitta Vata Vriddhi).

 OBJECTIVE

 To evaluate the efficacy of Shiroabhyanga, Padabhyanga, and Pratimarsha Nasya in comparisonwithAshwagandha Churna in PMS (w.s.r. to Rituvyatit Kalaja Pitta Vata Vriddhi).

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Married and unmarried females of age group 20 – 45 years Patients willing to participate in this trial through written informed consent Patients fulfilling the criteria of mild to moderate PMS as per PMSS.

排除标准

  • Females with menstrual irregularities Menstrual or gynecological disorders such as endometriosis, fibroid Allergy or hypersensitivity to treatment ingredients Use of hormonal contraceptives or treatments (birth control pills, hormone replacement therapy within last 3 months) Severe medical conditions such as Hyperthyroidism (TSH less than 0.1mIU/L), Anemia (Hb less than 7 gm/dl) Pregnant or lactating women Lactose intolerance (Because Trial drug Ashwagandha will be administered with milk).

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Arti

National Institute of Ayurveda

研究点 (1)

Loading locations...

相似试验